Fundamentals of Liver Disease - MASLD (2026)-Risk Stratisfication Infographic

Risk Stratisfication Infographic
Pdf Summary
The document outlines a strategy for managing liver health, particularly focusing on identifying and treating individuals at risk for significant fibrosis and cirrhosis. The primary objectives are to detect liver fibrosis early, recognize those requiring cirrhosis care, and intervene before cirrhosis develops. Screening includes assessing alcohol intake through tools like the AUDIT-C, offering universal hepatitis screening, and considering risk factors such as type 2 diabetes, known hepatic steatosis, obesity, metabolic syndrome, family history of cirrhosis, and excess alcohol consumption.<br /><br />The document highlights the importance of using various tests for screening and risk stratification. The first-line test recommended is FIB-4, which helps in categorizing patients into low, indeterminate, or high-risk groups. Based on the initial screening, a second-line test such as VCTE (Vibration Controlled Transient Elastography) or ELF (Enhanced Liver Fibrosis) is suggested for further assessment.<br /><br />Patients identified with indeterminate or high-risk levels require repeated non-invasive tests (NIT) every 1-3 years. In cases where second-time testing is unavailable, there is diagnostic uncertainty, atypical presentations, or markedly elevated liver enzymes, referral to a gastrointestinal/hepatology specialist is advised.<br /><br />The importance of monitoring lifestyle factors, particularly alcohol consumption, and medical conditions that contribute to liver disease is underscored. The document serves as a guide on when to screen individuals and how to manage those identified at risk for liver disease, promoting preventive care and appropriate referrals to specialists when necessary. It also mentions additional resources for MASLD (Metabolic Associated Steatotic Liver Disease) and MASH (Metabolic Associated Steatohepatitis), which are newer classifications within liver disease management.
Keywords
liver health
fibrosis
cirrhosis
screening
AUDIT-C
FIB-4
VCTE
ELF
MASLD
MASH